The development and initial validation of the Russian version of the BASIS-24

Thumbnail Image
Madden, Lynn
Farnum, Scott
Bromberg, Daniel
Barry, Declan
Mazhnaya, Alyona
Fomenko, Tetiana
Meteliuk, Anna
Marcus, Ruthanne
Rozanova, Julia
Poklad, Iurii
Journal Title
Journal ISSN
Volume Title
Background: Efficient and linguistically appropriate instruments are needed to assess response to addiction treatment, including severity of addiction/mental health status. This is critical for Russian-speaking persons in Eastern Europe and Central Asia (EECA) where Medications for Opioid Use Disorder (MOUD) remain underscaled to address expanding and intertwined opioid, HIV, HCV and tuberculosis epidemics. We developed and conducted a pilot validation of a Russian version of the 24-item Behavior and Symptom Identification Scale (BASIS-24), an addiction/mental health severity instrument with six subscales, previously validated in English. Methods: Using the Mapi approach, we reviewed, translated, and back-translated the content to Russian, pilot-tested the Russian-version (BASIS-24-R) among new MOUD patients in Ukraine (N = 283). For a subset of patients (n = 44), test-rest was performed 48 h after admission to reassess reliability of BASIS-24-R. Exploratory principal component analysis (PCA) assessed underlying structure of BASIS-24-R. Results: Cronbach alpha coefficients for overall BASIS-24-R and 5 subscales exceeded 0.65; coefficient for Relationship subscale was 0.42. The Pearson correlation coefficients for overall score and all subscales on the BASIS-24-R exceeded 0.8. Each item loaded onto factors that corresponded with English BASIS-24 subscales ≥ 0.4 in PCA. Conclusion: Initial version of BASIS-24-R appears statistically valid in Russian. Use of the BASIS-24-R has potential to guide MOUD treatment delivery in the EECA region and help to align addiction treatment with HIV prevention goals in a region where HIV is concentrated in people who inject opioids and where healthcare professionals have not traditionally perceived MOUD as effective treatment, particularly for those with mental health co-morbidities.
medications for Opioid Use Disorder (MOUD), Eastern Europe and Central Asia (EECA), HIV, BASIS-24-R, PWID, implementation Science, validation, article
The development and initial validation of the Russian version of the BASIS-24 / Lynn M. Madden, Scott O. Farnum, Daniel J. Bromberg, Declan T. Barry, Alyona Mazhnaya, Tetiana Fomenko, Anna Meteliuk, Ruthanne Marcus, Julia Rozanova, Iurii Poklad, Sergii Dvoriak, Frederick L. Altice // Addiction Science and Clinical Practice. - 2022. - Vol. 17, Issue 1. - Article number 65. - P. 1-7. -